Právní předpis byl sestaven k datu 01.07.2024.
Zobrazené znění právního předpisu je účinné od 01.07.2024 do 31.12.2024.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
č. 194/2021 Sb. - Čl. II
č. 159/2022 Sb. - Čl. II
č. 228/2023 Sb. - Čl. II
č. 52/2024 Sb. - Čl. II
č. 176/2024 Sb. - Čl. II
463
NAŘÍZENÍ VLÁDY
ze dne 18. xxxxxxxx 2013
x xxxxxxxxx xxxxxxxxxx látek
Vláda xxxxxxxx xxxxx §44c xxxx. 1 xxxxxx x. 167/1998 Sb., x xxxxxxxxxx látkách x o změně xxxxxxxxx dalších xxxxxx, xx znění xxxxxx x. 273/2013 Xx.:
§1
Toto xxxxxxxx stanoví
a) x příloze č. 1 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Jednotné xxxxxx x xxxxxxxx xxxxxxx1) x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx xx x důvodu xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx jen xx xxxxxxx xxxxxxxx x xxxxxxxxx, nebo xx x tohoto xxxxxx xxxxx xxxxxxxxxx, xxx léčivé xxxxxxxxx xxxxxxxxxx xxxx omamné xxxxx xxxx xxxxxxxx x xxxxxxx pouze xx xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu xx pravého horního xxxx,
(xxxx xxx "seznam x. 1 omamných xxxxx"),
x) x příloze č. 2 x xxxxxx nařízení xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Seznamu XX xxxxx Xxxxxxxx xxxxxx o xxxxxxxx xxxxxxx x
2. dalších xxxxxxxx xxxxx, u xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx zdraví, xxxxx xxxxxxxxxx, aby xxxxxx přípravky xxxxxxxxxx xxxx omamné xxxxx xxxx xxxxxxxx x xxxxxxx na recept xxxx žádanku xxx xxxxxxxx xxxxxx pruhem,
(dále xxx "xxxxxx x. 2 xxxxxxxx xxxxx"),
x) x příloze č. 3 k xxxxxx xxxxxxxx seznam
1. xxxxxxxx xxxxx xxxxxxxxxx xx Seznamu XX xxxxx Xxxxxxxx úmluvy x xxxxxxxx xxxxxxx x
2. dalších xxxxxxxx xxxxx, x nichž xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, že xxxxxxxxxxxxx xxxx nepřímo xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx látky x xxxxxxxxx xxxxxxxxxx xxxx xxxxxx látky xxxx xxxxxxxxx xxxxx x xxxxxxxx výzkumným, xxxxxxxx a xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxx x povolení x xxxxxxxxx,
(xxxx xxx "xxxxxx č. 3 xxxxxxxx látek"),
d) x příloze č. 4 x xxxxxx xxxxxxxx xxxxxx
1. psychotropních xxxxx xxxxxxxxxx xx Xxxxxxx X xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) x
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx xx z xxxxxx rozsahu xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, aby xxxxx x xxxxxxxxx xxxxxxxxxx tyto xxxxxxxxxxxx xxxxx xxxx xxxxxxxxx xxxxx x omezeným xxxxxxxxx, xxxxxxxx x xxxxx omezeným xxxxxxxxxxxxx xxxxxx vymezeným v xxxxxxxx k xxxxxxxxx,
(xxxx xxx "xxxxxx č. 4 psychotropních xxxxx"),
x) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx látek zařazených xx Xxxxxxx XX xxxxx Úmluvy o xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx psychotropních xxxxx, x xxxxx xx x důvodu xxxxxxx xxxxxx zneužívání xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx ohrožují xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx xxx na xxxxxxx povolení k xxxxxxxxx, nebo xx x xxxxxx xxxxxx xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx psychotropní látky xxxx xxxxxxxx x xxxxxxx xxxxx na xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxx xxxxxxxxxx x levého xxxxxxx xxxx xx xxxxxxx horního rohu,
(dále xxx "xxxxxx č. 5 xxxxxxxxxxxxxx látek"),
f) x příloze č. 6 k xxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Seznamu XXX xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx,
x) x příloze č. 7 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx zařazených xx Xxxxxxx IV xxxxx Xxxxxx x psychotropních xxxxxxx a
2. xxxxxxx xxxxxxxxxxxxxx látek, x xxxxx xx z xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují xxxxxx, xxxxx xxxxxxxxxx, aby xxxxxx xxxxxxxxx obsahující xxxx látky xxxx xxxxxxxx x xxxxxxx xx xxxxxx nebo xxxxxxx xxx xxxxxxxx xxxxxx xxxxxx,
(xxxx jen "xxxxxx x. 7 xxxxxxxxxxxxxx látek"), x
x) x příloze č. 8 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxx zařazených do Xxxxxxx XXX podle Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx,
(xxxx xxx "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx nařízení xxxx xxxxxxxx v xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES xx xxx 22. června 1998 x postupu xxx poskytování xxxxxxxxx x oblasti xxxxx x technických xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx, x xxxxxxx znění.
(2) Xxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx Xxxxxxxx xxxx xxxxxxxx xx xxxxxxxxxx xxxxx3).
§3
Toto nařízení xxxxxx xxxxxxxxx dnem 1. xxxxx 2014.
Příloha x. 1 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 1 omamných xxxxx
Xxxxxxxxxxx nechráněný xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx-6,14-xxxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxx-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxx-2-xxxxxxxxxxx)-4-xxxxxxxx]xxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxx xxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx)xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
Xxxxxxxxxx |
2,2-xxxxxxx-4-[4-(2-xxx-3-xxxxxxxxx-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx)xxxxxxxxxx]xxxxxxxxxxx |
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
Xxxxxxx |
xxxxxxxx (x.X.2X,3X5X)3-xxxxxxx-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, xxxx xxxxxx x xxxxxxxx, x xxxxxxx xx xxxxx xxxxxx ekgonin x kokain |
|
Ethylmethylthiambuten |
N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin |
|
Etonitazen |
1-[2-(diethylamino)ethyl]-2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol |
|
Etoxeridin |
ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát |
|
Extrakt z xxxxxx xxx xxxxxxx xxxxxxx |
Xxxxxxx x konopí xxxxxxxx x přípravě xxxxxxxx xxxxxxxxx xx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
X-(1-xxxxxx-2-xxxxxxxxxxxxxxx)xxxxxxxxxxxx |
|
Xxxxxxxxx |
(2XX,6X,11X)-3-xxxxxxxx-6,11-xxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
|
Xxxxxxxxxx |
17-xxxxxxxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-[2-(xxxxxxxxxxx)xxxxx]xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α,14-xxxxx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxxxx |
xxxxx-4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxx-5-xxxxxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
xxxxxx-1-xxxxxxxx-4-(X-xxxxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxxxx |
2-(4-xxxxxxxxxxx)-1-[2-(xxxxxxxxxxxx)xxxxx]-5-xxxxx-1X-xxxxxxxxxxxx |
|
Xxxxxxx |
xxxxxxxx 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xxxxxx)xxxxx]xxx}xxxxxx |
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxx x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx xxxxxxxxx xxxxxxx technologickou xxxxxxx xxxxxxxx |
|
Xxxxxx xxxxxxx x xxxxxxxx |
X xxxxxxxx látky xxxxxx xxxxxxx x xxxxxxxx, xxxxx obsahuje 1 % látek xx xxxxxxx xxxxxxxxxxxxxxxxxxxx x xxxxxxx podmínku xxxxxxxxxxx xxxxx xxxxxx x obecné xxxxxxxxxxx xxxxxxx |
|
Xxxxxx xxx xxxxxxx xxxxxxx |
||
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx dextromethorfan [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx omamných xxxxx xxxxxxxxx x této xxxxxxx |
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxxx [(+)-3-xxxxxxx-17-xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx omamných xxxxx xxxxxxxxx v xxxx xxxxxxx |
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3-xxxxxxxxx-8-xx |
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
Xxxxxxxx, xxxxxxxxxxx |
4-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,5α-xxxxx-6,17-xxxxxxxxxxxxxx-6-xx-3-xx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5-xxxxx-6,17-xxxxxxxxxxxxxxxx-3,6-xxxx |
|
Xxxxxxx |
4,5-xxxxx-3-xxxxxxx-5,17-xxxxxxxxxxxxxxxx-6-xx |
|
Xxxxxxx, meziprodukt |
2,2-difenyl-3-methyl-4-morfolinobutanová xxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxx xxxxxxxx |
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(2-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx |
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x xxxx xxxxxxxx morfinu xx čtyřvazným xxxxxxx xxxxxx derivátů morfin-N-oxidu |
Xxxxxx-X-xxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
Xxxxxxxxxxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxx |
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
Xxxxx |
Xxxxx homeopaticky xxxxxxxxxx xxxxxxxxx, jejichž xxxxxx xxxxxx je xxxxx xxx X4 xxxx XX2 |
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
Xxxxxxxx, meziprodukt X |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
Xxxxxxxx, xxxxxxxxxxx B |
ethyl-4-fenylpiperidin-4-karboxylát |
|
Pethidin, xxxxxxxxxxx X |
xxxxxxxx 4-fenyl-1-methylpiperidin-4-karboxylová |
|
Piminodin |
ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát |
|
Piritramid |
1'-(3,3-difenyl-3-kyanpropyl)-4'-ureido-1,4'-bipiperidin |
|
Proheptazin |
4-fenyl-1,3-dimethylazepan-4-yl-propanoát |
|
Properidin |
isopropyl-4-fenyl-1-methylpiperidin-4-karboxylát |
|
Racemethorfan |
(9RS,13RS,14RS)-3-methoxy-17-methylmorfinan |
|
Racemoramid |
(3RS)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
Racemorfan |
(9RS,13RS,14RS)-17-methylmorfinan-3-ol |
|
Remifentanil |
methyl-3-[4-(N-acetonylanilino)-4-(methoxykarbonyl)]piperidino]propanoát |
|
Sufentanil |
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
Tapentadol |
3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol |
|
Thebain |
4,5α-epoxy-3,6-dimethoxy-17-methylmorfína-6,8-dien |
|
Thebakon |
(5R)-4,5-epoxy-3-methoxy-17-methylmorfin-6-en-6-yl-acetát |
|
Thiofentanyl |
N-{1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
Tilidin |
ethyl-(1RS,2RS)-2-(dimethylamino)-1-fenylcyklohex-3-en-1-karboxylát |
|
Trimeperidin |
(RS)-4-fenyl-4-(1,2,5-trimethylpiperidin-4-yl)propanoát |
Včetně izomerů xxxxxxxx xxxxx uvedených x xxxxx xxxxxxx, xxxx xxxxxx x xxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx a xxxx xxxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx, xxxxxx solí xxxxxxx, xxxxxx a éterů xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx existovat.
Příloha x. 2 x nařízení xxxxx x. 463/2013 Sb.
Seznam x. 2 omamných xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx uvedených x xxxxx xxxxxxx, xxxx xxxx omamných látek xxxxxxxxx v xxxxx xxxxxxx, xxxxxx xxxx xxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx soli xxxxx xxxxxxxxx.
Xxxxxxx x. 3 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 3 xxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný název |
Další xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxx |
XXX 73750; benzylacetylfentanyl |
N-fenyl-N-(1-benzyl-piperidin-4-yl)-acetamid |
|
Acetylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid |
||
Acryloylfentanyl |
Acrylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid |
|
AH-7921 |
3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid |
||
AP-237 |
bucinnazin; 1-X-xxxxxxx-4-xxxxxxxxxxxxxxxxxx; |
1-[4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xxxxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX-X; xxxxxxxxxxxx-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2X-1,3-xxxxxxxxxxx-5-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-(1-xxxxxx-xxxxxxxxx-4-xx)xxxxxxxx |
||
Xxxxxxxxxxxxxxx |
xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxx |
Xxxxxx-X; X4129 |
X-xxxx\-X-[1-(xxxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
Xxxxxxxxxxxx1xxxxxxx 1 |
Xxxxxx XxX |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxx |
X4793x;X47931X |
4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)xxxxxxxx |
|
Xxxxxxx | Xxxxxxxxx | 3-{1-[1-(4-xxxxxxxxx)xxxxx]xxxxxxxxx-4-xx}-1X-xxxxxxxxxxxx-2-xx | |
Xxxxxxxxxxx |
2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-5-xxxxx-1X-xxxxxxxxxxxx-1-xxxxxxxxx |
||
4-Xxxxxxxxxxxxxxxxxxxxx |
4-Xx-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx-X; CP-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid |
|
Cyklopropylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid |
||
Desomorfin |
4,5α-epoxy-17-methylmorfinan-3-ol |
||
Despropionyl-2-fluor xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxxxxxxxx-4-xxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxx |
xxxxxxxxxxxxxx |
2-[2-[(4-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]-X,X-xxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxx | 2-[(4-xxxxxxxxxxx) xxxxxx-5-xxxxx-1-(2-xxxxxxxxxx-1-xxxxxxx)-1X-xxxx-xxxxxxxx | ||
Xxxxxxx |
(5X,6X,7X, 14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
||
Xxxxxxxx xxxxxxxxx analog |
Butyrfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid |
|
3-Fenylpropanoylfentanyl |
β'-fenylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-3-fenylpropanamid |
hydrocinnamoylfentanyl |
Flunitazen |
N,N-diethyl-2-{2-[(4-fluorfenyl)methyl]-5-nitro-1H-benzimidazol-1-yl}ethanamin |
||
4-Fluor-butyrfentanyl |
4F-BF |
N-(4-fluorfenyl)-N-[(1-(2-fenylethyl)-4-piperidinyl)]butanamid |
|
4-Fluor-cyklopropylbenzylfentanyl |
para-fluorcyklopropylbenzyl-fentanyl |
N-(4-fluorfenyl)-N-(1-benzylpiperidin-4-yl)-cyklopropankarboxamid |
|
2-Fluorfentanyl |
Ortofluorfentanyl |
N-(2-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
2-FF, x-XX |
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
4-Xxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxx; 4F-furanyl xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxxxx-4-xx)xxxxx-2-xxxxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
3-Xxxxxxxxxxxxxxxxxxxxxxxxxx |
xxxxx-xxxxxxxxxxxxxxxxxx-xxxxxxxx |
X-(3-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxxx |
XX-X; 2-furanoylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid |
|
(iso)Butyryl-F-fentanyl X-xxxxxx xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
||
4-xxxxxxxxxxxxxxxxxxxx |
4-XX-XX; xxxx-xxxxxxxxxxxxxxxxxxxxxx |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxxxxxx |
|
Xxxxxxxxx-X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-(xxxxxx-2-xx)xxxxxxxx |
||
Xxxxxxxxxxxx |
X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xxxxxxxxx |
||
Xxxxxxxxxxx |
1-[4-(3-xxxxxxxxxxxx)-1-xxxxxxxxxxxxxxx-4-xx]xxxxxx-1-xx |
||
Xxxxxx |
X xxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx xxxxxxx x xxxxxxx x. 1 |
||
Xxxxxxxxxxxxxxxx |
(2X)-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxx-4-xx]-2-xxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
4-Xxxxxxxxxxxx xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxxxxx |
x-xxxxxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-xxxxxxxx |
|
2-Xxxxxx-XX-237 |
2-xxxxxx-xxxxxxxxxx |
1-[2-xxxxxx-4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xxxxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxx-X-47700 |
3,4-XXX-X-47700; |
X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxx[x][1,3]xxxxxx-5-xxxxxxxxxx |
|
α-Xxxxxxxxxxxxxx butanamid xxxxxx |
XX; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
3-Xxxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-3-xxxxxxxxx-2-xxxxxx |
|
Xxxxxxxxxxxxxx |
X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
Xxxxxxxxxxx |
X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]-5-xxxxxxxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
X-xxxxxx X-47931X |
X-xxxxxxxxxxxxxxxx |
4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
|
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxx, XXX, 127C49 |
1-(4,4-di(thiofen-2-yl)but-3-en-2-yl)piperidin |
|
Protonitazen | N,N-diethyl-5-nitro-2-[(4-propoxyfenyl)methyl]-1-H-benzimidazol-1-ethanamin) | ||
Pryskyřice z xxxxxx |
|||
Xxxxxxxxxxxxxxxxxxxxxxx |
XXX-X |
X-(1-xxxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX-xxxxxxxx; XXXX-X |
Ν-xxxxx-Ν-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxx xxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxxxxxxxx |
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-48800 |
2-(2,4-xxxxxxxxxxxx)-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
||
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-50488 |
3,4-xxxxxxx-X-xxxxxx-X-[2-(1-xxxxxxxxxxxx)xxxxxxxxxx] xxxxxxxxxxxxxx |
||
X-51754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; xxxxxxxx xxxxxxxxxx xxxxxx |
Xxxxxx xxxx xxxxxxxx látek xxxxxxxxx x této skupině xx všech případech, xxx tyto xxxx xxxxx existovat.
Příloha č. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) |
Další xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx obecný xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
1-(Xxxxxxxxxxxxxxxx)-2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-1X-xxxxxxxxxxxx-5-xxxxxxxxxx |
|||
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
1-(2-(Xxxxxxxxxxx)xxxxxxxxx)xxxxxxxx |
XXXXX |
2-(xxxxxxxxxxx)-1-(xxxxxxxx-1-xx)xxxxxx-1-xx |
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
1-Xxxxxxx |
1-xxxxxxxxx |
1-xxxxxxxx-1-xx-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
1x-XXX, 1P-LAD |
diethylamid xxxxxxxx 1-xxxxxxxxx lysergové; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx- -6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid |
||
2,3-Dimethylmetkathinon |
2,3-DMMC |
1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on |
|
2,3-Methylendioxymethkathinon |
2,3-MDMC |
1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on |
|
2,4,5-Trimethylmethkathinon |
2,4,5-TMMC |
||
2,4,6-Trimethoxyamfetamin |
TMA-6 |
1-(2,4,6-trimethoxyfenyl)propan-2-amin |
|
2,4-Dimethylethkathinon |
2,4-DMEC |
1-(2,4-dimethylfenyl)-2-(ethylamino)propan-1-on |
|
2,4-Dimethylmetkathinon |
2,4-DMMC |
1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
2',4'-Dimethyl-α-pyrrolidinpropiofenon |
2,4-DMPPP |
1-(2,4-dimethylfenyl)-2-pyrrolidin-1-yl-propan-1-on |
|
2,5-Dimethoxy-4-chloramfetamin |
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
|
2,5-Dimethoxy-4-jodamfetamin |
DOI |
1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin |
|
25B-NBOMe |
2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
Cimbi-36 |
|
25C-NBOMe |
2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
2C-C-NBOMe |
|
25I-NBF; 25X-XX2X; 2X-X-XXX, NBF-2C-I; Cimbi-21 |
2-(4-jod-2,5-dimethoxyfenyl)-N[(2-fluorfenyl)methyl]ethylamin |
||
25I-NBOH |
2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol |
2C-I-NBOH; Xxxxx-27 |
|
251-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2X-X-XXX |
2X-X-XXX |
2-(4-xxxx-2,3,6,7-xxxxxxxxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxxxxx |
|
2X-X |
2X-X |
2,5-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxx |
XX-25 |
2X-X |
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxxxxx |
2-Xx-2'-Xxx-XXX, |
2-(2-xxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX; 2-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2X-XXXXX; SGT-13 |
8-chinolinyl-3-[(4,4-difluoφiperidin-1-yl)sulfonyl]-4-methylbenzoát |
||
2-Chloramfetamin |
2-CA |
1-(2-chlorfenyl)propan-2-amin |
|
2-Chlorethkathinon |
2-CEC |
1-(2-chlorfenyl)-2-(ethylamino)propan-1-on |
|
2-Chlormethamfetamin |
2-CMA |
1-(2-chlorfenyl)-N-methylpropan-2-amin |
|
2-Chlormethkathinon |
2-CMC |
1-(2-chlorfenyl)-2-(methylamino)propan-1-on |
|
2-Chlorpentedron |
2-CPD |
1-(2-chlorfenyl)-2-(methylamino)pentan-1-on |
|
2-MAPB |
1-(benzofuran-2-yl)-N-methylpropan-2-amin |
||
2-Methoxymethylon |
N-methyl-bk-MMDA-2 |
1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-on |
|
2-Methylamfetamin |
2-MA |
(2RS)-1-(2-methylfenyl)propan-2-amin |
|
2-Methylethkathinon |
2-MEC |
2-(ethylamino)-1-(2-methylfenyl)propan-1-on |
|
2-Methylmetamfetamin |
2-MMA |
1-(2-methylfenyl)-N-methylpropan-2-amin |
|
2-Methylmetkathinon |
2-MMC |
2-(methylamino)-1-(2-methylfenyl)propan-1-on |
|
2-Methyl-N,N-dimethylkathinon |
2-MDMC |
1-(2-methylfenyl)-2-(dimethylamino)propan-1-on |
|
2-Methyl-N-ethylnorpentedron |
2-MEAP |
2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on |
|
2-Methylthioamfetamin |
2-MTA |
(2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin |
|
2-Pyrrolidin-3-methoxy-propiofenon |
α-PPP-MeO; XXxXXX |
3-xxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
3-(4-Xxxxxxxxxxxxxxxxxxxx)-1-xxxxxxxxxxx |
Xxx Xxxx |
[4-(xxxxxxxxxxxxx)xxxxx]-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
|
3-(x-Xxxxxxxxxxxxxx)-X-xxxxxxxxxxx |
(4-xxxxxxxxxxxx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
3',4'- Xxxxxxxxxxxxx-α-xxxxxx XXX |
XXXXX |
1-(3,4-xxxxxxxxxxxxxxxxxx)-2-xxxxxx-2-xxxxxxxxxxxxxxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxx |
3,4-XXXX; |
1-(3,4-xxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
xxxxxx (2X)-2-(3,4-xxxxxxxxxxxx)-2-[(2X)-xxxxxxxx-2-xx]xxxxxx |
|
3,4-Xxxxxxx-X,X-xxxxxxxxxxxxxxxxxxxx-xxxxxxxx |
3,4-XXXXXXX |
2-(xxxxxxxxxxxxxxxxxxxxx)-1-(3,4-xxxxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxx-α-XXX |
3,4-XXxX-α-XXX |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
3,4-XXxX-α-XXX |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
3',4'-Xxxxxxxxxxxxx-α-xxxxxxxxxxxxxxxx-xxxxx |
XXXXX |
(XX)-1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx |
|
3 ',4'-Xxxxxxxxxxxxx-α-XXX |
XXXXX |
1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
3 -Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX; 3-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-2-xxxx; X-xxxxx-3-xxxxxxxxxxxxxx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxx-α-XXX |
3X-α-XXX; 3F-PVP |
1-(3-fluorfenyl)-2-(1-pyrrolidin)pentan-1-on |
3-Fluor-α-PVP |
3-Hydroxyfenazepam |
3-HOP, XXXX, 3-xxxxxxxxxxxx, 3 -xx droxy fenazepam |
7-brom-5-(2-chlorfenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
|
3-Hydroxyfencyklidin |
3-HO-PCP; |
3-[1-(piperidin-1-yl)cyklohexyl] xxxxx |
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
3-Xxxxxxx xxxxxxxxxxx |
3-XxX-XXX |
X-xxxxx-1-(3-xxxxxxxxxxxx)xxxxxxxxxx-1-xxxx |
|
3-Xxxxxxx fencyklidin |
3-MeO-PCP |
1-[1-(3-methoxyfenyl)cyklohexyl]piperidin |
|
3-Methoxymethkathinon |
3-MeOMC |
1-(3-methoxyfenyl)-2-(methylamino)propan-1-on |
|
3-Methyl-4-fluormethkathinon |
3-Methylflefedron |
1-(4-fluor-3-methylfenyl)-2-(methylamino)propan-1-on |
|
3-Methylamfetamin |
3-MA |
(2RS)-1-(3-methylfenyl)propan-2-amin |
|
3-Methylethkathinon |
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
|
3-Methylmetamfetamin |
3-MMA |
1-(3-methylfenyl)-N-methylpropan-2-amin |
|
3-Methylmetkathinon |
3-MMC |
2-(methylamino)-1-(3-methylfenyl)propan-1-on |
|
3-Methyl-N,N-dimethylkathinon |
3-MDMC |
1-(3-methylfenyl)-2-(dimethylamino)propan-1-on |
|
3-Methyl-N-ethylnorpentedron |
3-MEAP |
2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on |
|
3-Methylthioamfetamin |
3-MTA |
(2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin |
|
4'-Fluor-4-methylaminorex |
4-FPO; x-X-4-xxxxxxxxxxxxxx |
5-(4-xxxxxxxxxx)-4,5-xxxxxxx-4-xxxxxx-2-xxxxxxxxxx |
|
4'-Xxxxxx-X-xxxxxxxxxxxxxxxxxx |
4'-xxxxxx-XxXX |
1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxx-1-xx)xxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XxXX |
4-xxxxxx-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XXX; MPPP |
(RS)-1-(4-methylfenyl)-2-(1-pyrrolidinyl)propan-1-on |
|
4'-Ethyl-α-PVP |
4'-ethyl-α-pyrrolidinopentiofenon |
1-(4-ethylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
4-Acetoxy-N-methyl-N-ethyltryptamin |
4-AcO-MET |
{3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl}acetát |
|
4-Bromethkathinon |
4-BEC |
1-(4-bromfenyl)-2-(ethylamino)propan-1-on |
|
4-Brommethkathinon |
4-BMC |
(RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on |
Brefedron |
4-Brom-α-pyrrolidinvalerofenon |
4Br-α-PVP |
1-(4-bromfenyl)-2-pyrrolidin-1-yl-pentan-1-on |
|
4-Brom-α-pyrrolidinpropiofenon |
4Br-α-PPP; xXXXX, 4Xx-XXX |
1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4X-XXX; x-xxxxxxxxxxxxxxxxxxxx |
xxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxxx)xxxxxx |
|
4-Xxxxxxxxxxxxx |
4-XX |
2-xxxxx-1-(4-xxxxxxxxxx)-xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
4X-XXX; 4-XXXX |
Xxxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxx)xxxxxx |
4X-XXX |
|
4-Xxxxx-X-xxxxxxxxxxxxx |
4X-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxx-1-xx |
|
4-Xxxxx-X-xxxxxxxxxxxxxx |
4X-XXX; 4-xxxxx-α-xxxxxxxxxx-xxxxxxxxxxx |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-X-xxxxxxxxxxxxxxxxxxxxx |
4X-XXX; 4F-NPP; 4F-NIPP |
1-(4-fluorfenyl)-2-(1-methylethylamino)pentan-1-on |
|
4-Fluorpentedron |
4-FPD; 4-X-xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxx-α-XXX; 4X-XXX; X-2370 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxx |
4X-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4X-α-XXX; 4X-XX8 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-X-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4X-xxxxx-XXxX; 4F-α-PiHP |
1-(4-fluorfenyl)-4-methyl-2-(pyrrolidin-1-yl)pentan-1-on |
|
4-Fluor-α-pyrrolidinoktanofenon |
4F-α-POP; 4X-XX9 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4X-XXXX-XXXX |
xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
4X-XXXX-XXXXXX; 4X-XXX |
xxxxxx (S)-2-({[1-(4-fluorbutyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
||
4-F-α-PVP xxxxxxxxx xxxxxx |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxx)xxxxxx-1-xx |
||
4-XXXXXXX |
4-xxxxxxx-3,3,4-xxxxxxxxx-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxx-1-xx |
||
4-Xxxxxxx-X-xxxxxx-X-xxxxx tryptamin |
4-HO-MET |
3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol |
Metocin; Xxxxxxxxxxx |
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx tryptamin |
4-HO-MiPT |
3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol |
Miprocin |
4-Chlor-α-pyrrolidinovalerofenon |
4-Cl-α-PVP |
1-(4-chlorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
4-Chloramfetamin |
4-CA |
1-(4-chlorfenyl)propan-2-amin |
PCA |
4-Chlordiazepam |
Ro5-4864, xxxxxxxxxxxxxx |
7-xxxxx-5-(4-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxxxxxx |
4-XXX; xxxxxxxxxxx, |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX \ |
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
4-Xxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXX; 4-CDMD |
1-(4-chlorfenyl)-2-(N,N-dimethylamino)propan-1-on |
|
4-Chlor-N-butylkathinon |
4-CBC |
2-(butylamino)-1-(4-chlorfenyl)propan-1-on |
4-Chlorbutylkathinon |
4-Chlorpentedron |
4-CPD |
1-(4-chlorfenyl)-2-(methylamino)pentan-1-on |
|
4-Chlor-α-pyrrolidinpropiofenon |
4-chlor-α-PPP |
1-(4-chlorfenyl)-2-(1-pyrrolidinyl)propan-1-on |
|
4-MAPB |
4-MAPB |
1-(benzofuran-4-yl)-N-methylpropan-2-amin |
|
4-Methoxy-α-pyrrolidinbutiofenon |
4-MeO-α-PBP; 4-XXXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX; 4-XxX-α-XX8 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxxx α-XXX; 4-XxX-α-XX9 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
4'-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-Xxxxxxx-α-XXX; MOPPP |
(RS)-1-(4-methoxyfenyl)-2-(1-pyrrolidinyl)propan-1-on |
|
4-MA |
|||
4-Methylbufedron |
4-Me-MABP |
2-(methylamino)-1-(4-methylfenyl)butan-1-on |
|
4-Methylethkathinon |
4-MEC |
2-(ethylamino)-1-(4-methylfenyl)propan-1-on |
|
4-Methylkathinon |
Normefedron; 4-XX |
2-xxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxx |
2-xxxxxxxxxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-xxxxxx-X-xxxxxxxxxxxxxx |
(4-XXX) |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx |
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
5 - Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
5-XXXx; xxxxxxx-α-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
5X-XXX48; 5X-XXXXXXX |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5Xx-XX-XXXXXX |
X-[(2X)-1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx]-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5Xx-XXXX-XXXXXX; 5Xx-XXX |
xxxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
5-Xx-xxxxxx XXX 018 indazol xxxxxx |
5Xx-XXX-018; 5Xx-XXX-018-X, XXX-018 xxxxxx xxxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
|
5 -Dihydrobenzofuranpyrovaleron |
5-DBFPV; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
5X-3,5-XX-XXXXXXXX; 5X-3,5-XX-XXXXXXX, XX-037 |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx |
||
5X-5,3-XX-XXXXXXXX; 5X-XX-XXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-5-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-X7XXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX57 |
xxxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXX |
xxxxxx (2X)-2-[[1-(5-xxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxxxxxxxxxx |
||
5X-XXX-XXXXXX; 5X-XXX |
xxxxxx-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
5X-XXX |
|
5X-X-X7XXXX |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXX |
X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XXX-XXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
5X-XXXXX-XXXXXXXXX |
5-(5-xxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxxxxxxx)-xxxxxx[4,3-x]xxxxx-1-xx |
||
5X-XXXX-XXXXXX |
xxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
5X-XXX-XXXXXX |
xxxxx 2-[[1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
5X-XXX-398; XX-2201; |
(4-chlornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]-methanon |
||
5F-MDMB-P7AICA |
methyl-2-{[1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]formamido}-3,3-dimethyl xxxxxxxx |
||
5X-XXXX-XXXX; |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
5X-XXXX-XXXXXX; 5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
5X-XXXX-2 |
1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
5X-XX-22 xxxxxxx analog |
chinolin-8-yl 1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
5X-XX-22; 5X-XXXXX |
8-xxxxxxxxxx xxxxx xxxxxxxx 1-(5-fluorpentyl)-1H-indol-3-karboxylové |
||
5-F-pentyl-3-pyridinoylindol |
[1-(5-fluorpentyl)-1H-indol-3-yl] (pyridin-3-yl)methanon |
||
5F-PY-PICA |
1-(5-fluorpentyl)-3-(pyrrolidin-1-karbonyl)-1-H-indol |
||
5F-PY-PINACA |
[1-(5-fluorpentyl)indazol-3-yl]-pyrrolidin-1-yl-methanon |
||
5F-SDB-005 |
naftalen-1-yl-1-(5-fluorpentyl)-1H-indazol-3-karboxylát |
||
5F-SDB-006 |
N-benzyl-1-(5-fluorpentyl)-l X-xxxxx-3-xxxxxxxxxx |
||
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
5-XxX-XXX |
5 -xxxxxxx-α-xxxxxxxxxxxxxxx |
||
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-xxxxxxx-X-xxxxxx-X-xxx-xxxxxx xxxxxxxxx |
||
5-Xxxxxxxxxxxx Ion |
N-methyl-bk-MMDA-5 |
1-(7-methoxybenzo[d] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
5-XXXx |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
6-XXX |
6-(2-xxxxxxxxxxx)xxxxxxxxxx |
||
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
X-796,260 |
[1-(2-xxxxxxxx-4-xxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
X-796,260 xxxxxx |
((X)-1-(1-(2-xxxxxxx-1-xx)xxxxx)xxxxx-3-xx)-3,4,4-xxxxxxxxxxxx-2-xx-1-xx |
||
X-834,735 |
1-(xxxxxxxxxxxxxxx-4-xxxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
X-836,339 |
X-[3-(2-xxxxxxxxxxxx)-4,5-xxxxxxxx-1,3-xxxxxxx-2-xxxxxx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-xxxxxxxxxx |
||
XX-005 |
[1-[(1-xxxxxx-2-xxxxxxxxxxx)xxxxxx]-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx |
||
XX-005 xxxxxx xxxxxx |
(1-(1-xxxxxxxxxxxx-2-xx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXX |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-[(2-fluorfenyl)methyl]-1H-indazol-3-karboxamid |
||
AB-CHMFUPPYCA; |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyklohexylmethyl)-3-(4-fluorfenyl)-1H-pyrazol-5-karboxamid |
||
AB-CHMINACA |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-l(cyklohexylmethyl)-1H-indazol-3-karboxamid |
||
AB-PINACA |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid |
||
AB-PINACA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluorpentyl)-1H-indazol-3-karboxamid |
||
Adamantyl-THPINACA |
N-(1-adamantyl)-1-(tetrahy xxxxxxxx-4-xxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx-xxxx |
||
XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-\X- xxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxxx |
X 41123 |
1-(8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,5-x][1,4]xxxxxxxxxxxxx-1-xx)-X,X-xxxxxxxxxxxxxx xxxx |
|
X-XXXXXXXX |
X-(1-xxxxxxxxx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-57 |
Xxxxxxx-1-xx-1-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
Xxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxx |
(2-(3-(xxxxxxxxxxx)-5-xxxxxx-4-X-1,2,4-xxxxxxx-4-xx)-5-xxxxxxxxxx)(xxxxx)xxxxxxxx |
||
XX-1220 |
1-[(1-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-1X-xxxxx-3-xx}(xxxxxx)-xxxxxxxx |
||
XX-1220 xxxxxx xxxxxx |
1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx] (naftyl)methanon |
||
AM-1248 |
adamant-1-yl(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanon |
||
AM-1248 xxxxxx xxxxxx |
xxxxxxx-1-xx(1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (naftalen-1-yl)methanon |
||
AM-2201 xxxxxxxxxxxx analog; XXXXXXXX |
(1-(5-xxxxxxxxxxx)-1X-xxxxx[x]xxxxxxxx-2-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XX-2201 xxxxxxx karboxamid xxxxxx |
X-1-xxxxxxxxxx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-2232 |
5-[3-(1-xxxxxxx)-1X-xxxxx-1-xx]xxxxxxxxxxxx |
||
XX-2233 |
1-[(X-xxxxxxxxxxxxxxx-2-xx)xxxxxx]-3-(2-xxxxxxxxxx)xxxxx |
||
XX-6527 |
1-xxxxxx-X-(xxxxxxxx-1-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XX-6527 5-xxxxxxxxxxx derivát |
1-(5-fluorpentyl)-N-(naftalen-1-yl)-1H-indol-3-kaboxamid |
||
AM-679 |
(2-iodfenyl)(1-pentyl-1H-indol-3-yl)methanon |
||
AM-694 |
1-[(5-fluorpentyl)-1H-indol-3-yl]-(2-iodfenyl)methanon |
||
AM-694 (ethyl xxxxxxxxx xxx) |
1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxx)xxxxx |
||
XX-694 (methyl xxxxxxxxx xxx) |
1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxxx)xxxxx |
||
XX-694 xxxxx xxxxxxx |
1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx |
||
XXX-4xx-XXXX |
xxxxxx-3-xxxxxx-2-[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xxxxxxxxxxx]xxxxxxxx |
||
XXX-XXXXXX |
xxxxxx 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xxxxxxxxxx]-3-xxxxxxxxxxxxxx |
||
XXX-XXXXXXXX; XXX-XXX |
Xxxxxx 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
XXX-XXXXXXXX |
|
XXX-XXXXXX |
Xxxxxx (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát |
||
AMB-CHMrNACA |
methyl 2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamid)-3-methylbutanoát |
||
APICA; XXX-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
XXX-XXXXXX |
X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(xxxxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
xx-2X-X; βx-2X-X |
2-xxxxx-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xx |
||
xx-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
||
xx-XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxx-1-xx |
||
XXXX; 3,4-XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxx |
8-xxxx-6-xxxxx-1-xxxxxx-4X-xxxxx[x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
||
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
|
XXX-018 |
xxxxxxxx-1-xx 1-pentyl-1H-indol-3-karboxylát |
||
CP 47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxxx-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
XX 47,497 (C8 + X2) |
2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(2-xxxxxxxxxxx-2-xx)xxxxx; 2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(xxxxx-3-xx)-xxxxx |
1,1-xxxxxxxx a 1-xxxxx xxxxxxx X8-xxxxxxxx |
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
XXXXX-4XX-X7XXXX |
1-(4-xxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-4XX-XXXXXX; XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-5X-X7XXXX |
1-(5-x:xxxφxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-5XXXXX |
1-(5-xxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-5XXXXXXX |
|||
XXXXX-XXXX |
1-xxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-XX-XXXXXXXXX |
5-(xxxxxxxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxx-xxxxx)xxxxxx[4,3-x]xxxxx-1-xx |
||
XXXXX-XXXXXXXXX; XXX-151 |
2-(1-xxxxxx-1-xxxxxxxxxx)-5-xxxxxx-xxxxxx[4,3-x]xxxxx-1-xx |
||
XXXXX-XXXX |
1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXXXX-XXXXXX |
1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXXXX-XXXXXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1-((xxxxxxxxxx-2X-xxxxx-4-xx)xxxxxx)-1-X-xxxxxxx-3-xxxxxxxxxx |
||
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxxx |
XXX-2; xxxxxxxx-2 |
2-xxxxx-9-xxxxxx-4-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
||
Xxxxxxxx-X-xxxxx-xxxxxxx |
X-XXX; 2-Xxx-XXX, xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
|
Xxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx |
Xxxxxxxxxxxxx |
Xxxxxxxxxx |
2-xxxxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
Xx 5-3448 |
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx] xxxx |
|
Xxxxxxxxx |
XXX; 1,2-XXX; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
Xxxxxxxxxxxxx |
Xx 07-4065 |
7-xxxxx-5-(2,6-xxxxxxxxxxxx)-1-xxxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XX-4662 |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxxx)-3΄,4΄-(xxxxxxxxxxxxx)xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-xxxxxx-1-xx |
|
XXXX-XXXXXXXX |
2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx xxxxxxxx |
||
XXX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(4-xxxxx-xxxxxxxx-1-xx)xxxxxxxx |
||
Xxxxxxxx |
XXXXX; xxxxxxxxxx; XXX |
X-xxxxx-1,2-xxxxxxxxxxxxxxxx |
|
XX-018 |
xxxxxxxx-1-xx(9-xxxxxx-9X-xxxxxxxx-3-xx)xxxxxxxx |
||
XX-2201 |
(9-(5-xxxxxxxxxxx)-9X-xxxxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-XXXXXXXX |
Xxxxx 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
Xxxxxxx |
XXXXX; xx-XXXX |
1-(xxxxx[x] [1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on |
N-ethyl-pentylon |
Ethkathinon |
Ethylpropion; X-xxxxxxxxxxxxxx; ETH-CAT |
2-ethylamino-1-fenyl-propan-1-on |
|
ETH-LAD |
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindo1-[4,3-fg]chinolin-9-karboxamid |
||
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
Ethylon |
bk-MDEA |
2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
Ethyltenamfetamin |
MDE, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxx |
XXX3219; Xxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-9-xxxxxx-67/-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
Xxxxxxx |
xx-XXXX, X-Xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|
XXX-XX-22 |
1-xxxxxx 1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xxxxxxxxxx |
||
Xxxxxxx |
xxxxxxxx |
4-xxxxx-3-xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxxxxxx |
Xx 11-5073/000 |
8-chlor-6-(2-fluorfenyl)-1-methyl -4H- [1,2,4]xxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
|
Xxxxxxxxxxxxx |
7-xxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxxx |
8-xxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxx-[4,3x] [1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
2-xxxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x] [1,2,4]xxxxxxx[4,3-x] [1,4] xxxxxxxx |
||
Xxxxxxxxxxxxx |
6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxx-4X-[1,2,4]xxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxx |
Xx 05-4435 |
5-(2-xxxxxxxxxx)-1,3-xxxxxxx-7-xxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|
XXX-144 |
[1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XXX-XXX48 |
X-((3x,5x,7x)-xxxxxxxxx-1-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXX-018 |
(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-XXX-22 |
xxxxxxxx-8-x1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XX-22 |
xxxxxxxx-8-xx-1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxx | XXXX | 6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx | |
Xxxxxxxxxxxxxxxxxxxx | XXXX; HHC-C6 | 6,6,9-trimethyl-3-hexyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | |
Hexahydrokanabinol | HHC | (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | S xxxxxxxx látky HHC, xxxxx xx obsažena x xxxxxxxx technického xxxxxx, xxxxxxxxxx xxxxxx, xxxxxx xxxxxxx x xxxxxxxx x xxxxxxxxx x xxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxx xxx 0,3 %. Xxxx xxxxxxx se xxxxxxxxxx xx xxxxxxxxx. |
Xxxxxxxxxxxxxxxxxx-X-xxxxxx | XXX-xxxxxx, XXX-X | [(6xX,10xX)-6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx] acetát | |
Hexahydrokanabioktyl | HHC-C8 | 6,6,9-trimethyl-3-oktyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | |
Hexahydrokanabutol | HHCB; HHC-C4 | 6,6,9-trimethyl-3-butyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | |
Hexedron |
β-propylmethcathinone |
2-(methylamino)-1-fenylhexan-1-on |
|
Hexylon |
βk-MBDH |
1-(1,3-benzodioxol-5-yl)-2-(methylamino)hexan-1-on |
|
HU-210 |
(6aR, 10xX)-9-(xxxxxxxxxxxxx)-6,6-xxxxxxxx-3-(2-xxxxxxxxxxx-2-xx)-6x,7,10,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
||
XX-331 |
3X,4X-x-xxxxxxxxxxx-3-xxxxxxx-2-x-xxxxxx-(1,8)-xxxx-3-xx-5-xxxxxx |
||
Xxxxxxxxxxxxxxxxxxx |
(2X,X)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxx |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-xxxxx-2-(xxxxxxxxxx-1-xx)-xxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
Xxxxxxxxxxx |
4-xxxxxx-2-(xxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxx |
XXXX |
xxxxxxxxx2-xxxxx-2-(2-xxxxxxxxx)xxxxxx |
|
XXX-907 |
X-(Xxxxx[1,3]xxxxxx-5-xxxxxxxx)-7-xxxxxxx-2-xxx-8-xxxxxxxxx-1,2-xxxxxxxxxxxxxxx-3-xxxxxxxxxx |
||
XXX 018 X-5-xxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX 018 N-5-chlorpentyl xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-007 |
1-xxxxxx-2-xxxxxx-3-(1-xxxxxxx)xxxxx |
||
XXX-018 |
(xxxxxxxx-1-xx)(x -pentyl-1H-indol-3-yl)methanon |
||
JWH-018 adamantoyl xxxxxxx; |
1-xxxxxx-3-(xxxxxxx-1-xxx)xxxxx |
||
XXX-018 xxxxxxxxxxxxxxx xxxxxxx |
[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-018 |
xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-018 xxxxxxx xxxxxx |
1-xxxxxxxxxx(1-xxxxxx-1X-xxxxxxx-3-xx)-xxxxxxxx |
||
XXX-019 |
1-xxxxx-3-(1-xxxxxxx)xxxxx |
||
XXX-022 |
xxxxxxxx-1-xx(2-(xxxx-4-xxxx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-030 |
xxxxxxxx-1-xx(1-xxxxxx-1X-xxxxxx-3-xx)xxxxxxxx |
||
XXX-071 |
(1-xxxxx-1X-xxxxx-3-xx)-1-xxxxxxxxx 1-methanon |
||
JWH-073 |
(1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
JWH-073 xxxxxx xxxxxxx |
1-xxxxx-3-(1-(4-xxxxxx)xxxxxxx)xxxxx) |
||
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 xxxxxxxx 2-xxxxxxxxxxx derivát |
(4-methylnaftalen-1-yl)(2-methyl 1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 xxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxxx-1-xx)(1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-145 |
xxxxxxxx-1-xx(1-xxxxxx-5-xxxxx-1X-xxxxxx-3-xx)xxxxxxxx |
||
XXX-182 |
1-xxxxxx-3-(4-xxxxxx-1-xxxxxxx)xxxxx |
||
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-203 |
2-(2-xxxxxxxxxx)-1-(1-xxxxxxxxxxx-3-xx)xxxxxxx |
||
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
XXX-2501 2-methylen-N-methyl-piperidyl xxxxxxx |
1-(2-xxxxxxxx-X-xxxxxxxxxxxxxxx)-3-(2-xxxxxxxxxxxxxxxxxx)xxxxx |
||
XXX-251 |
2-(2-xxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-302 |
1-xxxxxx-3-(3-xxxxxxxxxxxxxxxxxx)xxxxx |
||
XXX-307 |
(5-(2-xxxxxxxxxx)-1-xxxxxxxxxxxx-3-xx)-xxxxxxxx-1-xxxxxxxxxx |
||
XXX-307 xxxx xxxxxxx |
(5-(2-xxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-368 |
[5-(3-xxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
XXX-370 |
[5-(2-xxxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
XXX-387 |
1-xxxxxx-3-(4-xxxx-1-xxxxxxx)xxxxx |
||
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-412 |
|||
XXX-412 5-fluorpentyl xxxxxxx |
(4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx |
||
XXX-xxxxxxxxxxxxxxxx-8-xxxxxxxxxx; XX-22 |
xxxxxxxx-8-xx 1-(cyklohexylmethyl)-1H-indol-3-karboxylát |
||
Kathinon |
(2S)-2-amino-1-fenylpropan-1-on |
||
Klobromazolam |
phenazolam; XXX 4550445 |
8-brom-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]tnazolo[4,3-a] [1,4]xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-1-xxxxxx-8-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-(xxxxxxxxxxxxxxxxx)-7-xxxx-1,3-xxxxxxx-2X-[1,4]-xxxxxxxxxxxxx-2-xx |
||
XXX-701 |
1-(5-xxxxxxxxxxx)-X-xxxxx-xxxxx-3-xxxxxxxxxx |
||
XX2183240 |
X,X-xxxxxxxx-5-[(4-xxxxxxx)xxxxxx]xxxxxxxx-1-xxxxxxxxxx |
||
X5XXXX |
xxxxxx-1-(5-xxxxxxxxxxx)-1X-xxxxx-xxxxxxxxxx |
||
XXX-2201 |
1-(5-xxxxxxxxxxx)-3-(4-xxxxxx-xxxxxxx)xxxxx |
||
XXX-2201 xxxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](4-xxxxxx-xxxxxxxx-1-xx)-xxxxxxxx |
||
XXX-XXXXXXXX |
2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx kyselina |
||
MBZP |
1 -xxxxxx-4-xxxxxxxxxxxxxxx |
||
XXX 19 |
X-[(X)-(1-xxxxx-2-xxxxxxxx-3-xxxxxx)xxxxx]xxxxxxxx |
||
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
XXXX-4xx-XXXXXX |
(xxxxxx 3,3-xxxxxxxx-2-(1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxxx) xxxxxxxx) |
||
XXXX-XXXXXX |
xxxxxx 2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXXX |
xxxxxx 2-(9-(xxxxxxxxxxxxxxxx)-9X-xxxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx-xxxxx, xxxxxx ester |
||
MDMB-PCZCA |
methyl 3,3-xxxxxxxx-2-(9-xxxxxx-9 X-xxxxxxxx-3-xxxxxxxxxxx)xxxxxxxx |
||
XXXXX; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
Xxxxxxxxxxxx |
(X)-5-(2-xxxxxxxxxx)-3-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
(4-xxxxxxxxxxxxxxx-1-xx)-(1-xxxxxxxxxxx-3-xx)xxxxxxxx |
||
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxx, Dimethylpropion |
2-dimethylamino-1-fenylpropan-1-on |
|
Methamnetamin |
methylnaphetamine, |
X-xxxxxx-1-(xxxxxxxx-2-xx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxx |
X-(2-xxxxxxx-xX-xxxxxxxxxxx)-5X,8X,11X,14X-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
Xxxxxxxxxxxxxx |
XXXx, 2-Xxx-3'-xxxxxxx-XXXx |
2-(3-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxxx |
XX 690; XX-690; xxxxxxxxxxxxxxxx; Xx 05-4082; Xx 5-4082 |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2X,X)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
Xxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
Xxxxxxxx |
4-XXX-xXx; MEX |
(3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-on |
|
m-Chlorfenylpiperazin |
mCPP |
1-(3-chlorfenyl)piperazin |
|
M-CHMIC |
1-(cyklohexylmethyl)-2-methyl-indol-3-karboxylát |
||
MN-18 |
N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid |
||
MO-CHMINACA |
1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXxX-2201 |
xxxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxxx}-3-xxxxxxxxxxxxxx |
||
X-(2-xxxxxxxxxxxx)-X-(1-xxxxxxxxxxx)-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx |
|||
X,X-xxxxxxx-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx |
|||
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
X-xxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxx, NBH |
2-(butylamino)-1-fenylhexan-1-on |
|
N-butylpentylon |
butyl-pentylone, xxxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxx, XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
XXX-xxxxx analog |
bk-IBP; , xx-XXXXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
|
X-xxxxxxxxxxxxx |
XXX-XX; Xxxxxxxxxxxxxx; Xxxxx-Xxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxx-1-xx |
|
X-xxxxx-xxxxxxxxxxx |
XXxX |
2-(xxxxxxxxxx)-4-xxxxxx-1-xxxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
α-xxxxxxxxxxxxxxxxxx-xxx |
Xxxxxxxxx |
5-(2-xxxxxxxxxx)-3-xxxxxxx-7-xxxxx-1X-xxxxx[x][1,4]xxxxxxxx-2(3X)-xx |
||
X-xxxxxxxxxxxxxxxxx |
XxXX; X-xxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
X-xxxxxxxxxxxxxxxxxx |
XxXX; XXX, 2-XXX |
2-(xxxxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
|
Xxxxxxxxxx |
1-xxxxxx-8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
||
XX-2201, CBL-2201 |
naftalen-1-yl-1-(5-fluorpentyl)-1H-indol-3-karboxylát |
||
N-methyl-2-aminoindan |
N-methyl-2AI |
2,3-dihydro-N-methyl-1H-inden-2-amin |
NM-2AI |
N-methylbenzedron |
2-[benzyl(methyl)amino]-1-(4-methylfenyl)propan-1-on |
||
Norfludiazepam |
N-desalkylflurazepam, xxxxxxxx-xxxxxxxxxx, xxxxxxxxxxxxx, Xx 5-3367 |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-2-xx |
|
X-xxxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx }xxxxxx |
Xxxxxxxxxx |
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
Xxx 27569 |
5-xxxxx-3-xxxxx-X-{2-[4-(1-xxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx |
||
Xxx 27759 |
5-fluor-3-ethyl-N-{2-[4-(dimethylamino)fenyl]ethyl}-1H-indol-2-karboxamid |
||
Org 29647 |
5-xxxxx-3-xxxxx-X-(1-xxxxxxxxxxxxxxxx-3-xx)-3X-xxxxx-2-xxxxxxxxxx |
||
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
XX-22 indazol analog |
chinolin-8-yl-1-pentyl-1H-indazol-3-karboxylát |
||
Pentedron |
1-fenyl-2-(methylamino)pentan-1-on |
||
Pentylon |
Methylendioxypentedron; βx-XXXX |
(±)-1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
Xxxxxxxxxx |
XXX 48,098 |
(4-xxxxxxxxxxxx)-[2-xxxxxx-1-(2-xxxxxxxx-4-xxxxxxx)xxxxx-3-xx]xxxxxxxx |
|
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxx; XX |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxx |
X-xxxxxxxxxxxxxxxxxx; |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
XX8, α-XXXX |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
XX9, α-XXX |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
Xxxxxxxxx |
8-xxxx-1-xxxxxx-6-(xxxxxxx-2-xx)-4X-[1,2,4]xxxxxxxx[4,3 -x] [1,4]benzodiazepin |
||
RCS-4 |
(4-methoxyfenyl)(l -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-4 xxxxx izomer |
(2-methoxyfenyl)(l -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-4(X4) |
4-xxxxxxxxxxx1-(1-xxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
Xxxxxxxxxxxx |
XXX, PCPY |
1-(1-fenylcyklohexyl)pyrrolidin |
|
Salvinorin X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx |
||
XXX-005 |
xxxxxxxx-1-xx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-006 |
X-xxxxxx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-006 X-xxxxx xxxxxx |
1-xxxxxx-X-xxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
XXX-135 |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
Xxxxxxxx |
xXxXXX; XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxx-xxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxxxx | XXXX | (6xX,10xX)-3-xxxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx | Xxxxxx xxxxx-8-xxxxxxx. X xxxxxxxx látky XXXX, xxxxx je xxxxxxxx x xxxxxxxx xxxxxxxxxxx xxxxxx, technickém konopí, xxxxxx extrakt a xxxxxxxx a xxxxxxxxx x technického konopí x množství nižším xxx 0,3 %. Xxxx výjimka xx xxxxxxxxxx xx xxxxxxxxx. |
Xxxxxxxxxxxxxxxxxxxxx | XXXX; XXX-X6 | (6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx | Xxxxxx delta-8-izomeru. X xxxxxxxx xxxxx THCH, xxxxx xx obsažena x xxxxxxxx xxxxxxxxxxx xxxxxx, xxxxxxxxxx xxxxxx, xxxxxx xxxxxxx x xxxxxxxx x přípravku x xxxxxxxxxxx xxxxxx x xxxxxxxx nižším xxx 0,3 %. Xxxx výjimka se xxxxxxxxxx na xxxxxxxxx. |
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-, Δ6α(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-xxxxxxxxxxxxxxxxxxxx x xxxxxx xxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx | XXX-X8 | (6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx | Xxxxxx xxxxx-8-xxxxxxx. |
Xxxxxxxxxxxxxxxxxxx | XXXX; XXX-X4 | (6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx | Xxxxxx xxxxx-8-xxxxxxx. S xxxxxxxx xxxxx THCB, xxxxx xx obsažena x xxxxxxxx xxxxxxxxxxx xxxxxx, xxxxxxxxxx xxxxxx, xxxxxx xxxxxxx x xxxxxxxx x xxxxxxxxx x xxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxx xxx 0,3 %. Xxxx xxxxxxx se xxxxxxxxxx na xxxxxxxxx. |
Xxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xxxxx |
||
XXX-2201 |
5X-XXX-018-X, |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx] (1 -xxxxxx)xxxxxxxx |
|
XX-XXX; 3',4'-tetramethylene-α-PBP |
2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronatalen-2-yl)butan-1-on |
||
TH-PHP; 2-pyrrohdin-1-yl-1-tetralin-6-yl- xxxxx-1-xx |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxx-1-xx |
||
XX-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxx-1-xx |
||
xxxxx-XX 47,497-X8 |
5-(1,1-xxxxxxxxxxxxx)-2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-xxxxx |
||
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
XX-144(-2X); |
[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
XX-144xxxxxx xxxxxxx |
(1-xxxxxx-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx |
||
XX-144X-(5-xxxxxxxxxxx) xxxxxxx |
(1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
XXX-597 |
[3-(3-xxxxxxxxxxxxxx)xxxxx]-X-xxxxxxxxxxxxxxxxxx |
||
XXX-754 |
6-xxxxxx-2-[(4-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxx-4-xx |
||
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
XXX 55212-2 |
(X)-(+)-[2,3-xxxxxxx-5-xxxxxx-3-(4-xxxxxxxxxxxxxxxx)xxxxxxx[1,2,3-xx]-1,4-xxxxxxxxxx-6-xxxxxxxxxxx-1-xxxxxxxxxx |
||
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-ΡιΗΡ |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxx |
α-XxxXX |
1-xxxxx-2-(xxxxxxxxx-1-xx)xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxx |
α-XXX; PV-10; xxxxx-xxxxxxxxx-xxxxxxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
β-Xxxx-xxxxxxxxxxxxxxxxxxxxxxxx |
xx-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx látek, xx xx xxxxxxxx xxxxxxx, xxxxxxxxx x xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx podle xxxxxxxxxx xxxxxxxxxx xxxxxxxx, x xxxx x esterů xxxxxxxxxxxxxx xxxxx uvedených x xxxxx xxxxxxx xx xxxxx případech, xxx mohou existovat..
Xxxxxxx č. 5 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxxxxx |
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) amino]heptanová |
||
Buprenofin |
(2S)-2-[(5R,6R,7R,14S)-17-(cyklopropylmethyl)-4,5α-epoxy-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx butan-2-ol |
||
Bromdimethoxyfenethyl amin |
2C-B |
(4-brom-2,5-dimethoxyfenethyl)amin |
|
Dexamfetamin |
(2S)-1-fenylpropan-2-amin |
||
Fencyklidin |
PCP |
1-(1-fenylcyklohexyl)piperidin |
|
Fenetylin |
7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H- xxxxx-2,6-xxxx |
||
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
XXX |
xxxxxxxx 4-hydroxybutanová |
||
Levamfetamin |
(2RS)-1-fenylpropan-2-amin |
||
Levmetamfetamin |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
Lisdexamfetamin | (2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid | ||
Meklochalon |
3-(2-chlorfenyl)-2-methyl-1,2-dihydrochinazolin-4(3H)-on |
||
Metachalon |
2-rnethyl-3-(2-methylfenyl)-1,2-dihydrochinazolin-4(3H)-on |
||
Metamfetamin |
(2S)-1-fenyl-N-methylpropan-2-amin |
||
Metamfetamin xxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxxx |
xxxxxx-(2XX)-2-xxxxx-2-[(2XX)-xxxxxxxxx-2-xx]xxxxxx |
||
Xxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx xxxxxxxxxxxxx x xxxxxx |
xxxx. (-)-trans-Δ9-THC |
Zipeprol |
(2RS)-1-fenyl-1-methoxy-3-[4-(2-methoxyfenethyl)piperazin-1-yl] propan-2ol |
Včetně xxxx látek xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx je xxxxx.
Xxxxxxx x. 6 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxx mezinárodní nechráněný xxxxx xxxx obecný xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxx |
xxxxxxxx 5-allyl-5-isobutylbarbiturová |
||
Cyklobarbital |
kyselina 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
Xxxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5[(1XX)-1-xxxxxxxxxxx]xxxxxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx všech xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx je xxxxx.
Xxxxxxx č. 7 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxx mezinárodní nechráněný xxxxx nebo obecný xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxx |
XX 718; XX 6008; Xxxxxxxxxx; |
5-xxxxx-1,3,6,7,8,9-xxxxxxxxx-2X-[1]xxxxxxxxxxx[2,3-x] [1,4]xxxxxxxx-2-xx |
|
Xxxxxxxxxxx |
(+)-X-xxxxxx-X-(2-xxxxx-1-xxxxxxxxxx)-X-xxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
1-xxxxxxxxxxxxxxx |
||
Xxxxxxxxxx |
7-xxxx-5-(2-xxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-ƒ][1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx |
||
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
Cinazepam |
BD-798; |
4-[[7-brom-5-(2-chlorfenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]oxy]-4-oxo-butanová xxxxxxxx |
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx)xxxxxxxx |
||
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx |
7-Xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
(+)-1-xxxxx-2-[(2-xxxxxxxxx)xxxxx] xxxxxx |
||
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
XX-xxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
XX-xxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxxxxxxxxxx |
||
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-4,7(6X)-xxxx |
||
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxxx-2,4(3X,5X)-xxxx |
||
Xxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X-xxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2.1-α]-xxxxxxxx-5-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx kyselina |
||
Methyprylon |
3,3-diethyl-5-methylpiperidin-2,4-dion |
||
Midazolam |
8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin |
||
Nimetazepam |
5-fenyl-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Nitrazepam |
5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Nordazepam |
7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Oxazepam |
7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
Oxazolam |
10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydrooxazolo[3,2-d] [1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
Xxxxxxx |
5-xxxxx-2-xxxxx-1,3-xxxxxxxxxx-4-xx |
||
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(xxxx-2-xx-1-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx |
xxxxxxx(2-xxxxxxxxx)xxxxxxxx |
||
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxxx |
(+)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
Xxxxxxxxx | Xxxxxxxxx, Emandaxin, EGYT 341 Xxxxxxxxx, Xxxxxx, XX | 1-(3,4-xxxxxxxxxxxxxx)-5-xxxxx-7,8-xxxxxxxxx-4-xxxxxx-5X-2,3-xxxxxxxxxxxxx | |
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxx[1,2-x]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxx seznamu ve xxxxx xxxxxxxxx, kdy xxxx soli xxxxx xxxxxxxxx.
Příloha č. 8 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 8 xxxxxxxxx xxxxxxxxx
Xxxxxxxxx obsahující: |
Podmínky: |
||
1) |
jednu z xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxxxx xxxxx (xxxxxxx xxxx omamných) a xxxxxxxx omamné xxxxx |
|
x) |
x xxxxx tabletě, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx xxxxx xxxxxxxxxx 100 xx, |
||
x) |
x roztoku xxxxx xxx xxxxxxxxxxx xxxxx než 2,5 % |
||
2) |
xxxxxxxxx |
x) |
Xxxxxxxx difenoxinu xxxxx xxxxxxxxxx x jedné xxxxxxx, tobolce, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 xx. |
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 5 % k xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, kapsli, xxxxxx, čípku, xxxx. xxxx lékové xxxxx. |
||
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx nesmí xxxxxxxxxx x jedné tabletě, xxxxxxx, xxxxxx, xxxxx, xxxx. v jiné xxxxxx xxxxx 2,5 xx. |
x) |
Xxxxxxxx atropin-sulfátu xxxx xxx nejméně 1 % k množství xxxxxxxxxxxx x jedné xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx lékové xxxxx. |
||
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
x) |
xxxxx xxxxxxxxxx 135 xx x xxxxx xxxxxxx, tobolce, ampuli, xxxxx, příp. x xxxx lékové xxxxx. |
||
x) |
x xxxxxxx nesmí xxx xxxxxxxxxxx xxxxx xxx 2,5 %. |
||
Přípravek xxxxx xxxxxxxxx žádnou psychotropní xxxxx. |
|||
5) |
xxxxxx |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx xxxxx xxxxxxxxxx 0,2 %. |
x) |
Xxxx xxxxx xxxxxxxxx jednu nebo xxxx xxxxxxx látek (xxxxxxx však omamných). |
||
Omamná xxxxx x xxxxxxxxx xxxxxxxx xxxxx xxx xxxxxx xxxxxxx xxxx x xxxxxxx množství, xxx xxxxxxxx veřejné xxxxxx |
|||
7) |
xxxxxxxxxxxxx xxxxxx x xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx nesmí xxx xxxxx xxx 10 %. |
x) |
Xxxxxxxx ipekakuanhového xxxxxx xxxxx být vyšší xxx 10 %. |
||
x} |
Xxxxxxxx xxxxx nebo xxxx xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxxx) nesmí xxx xxxxx než 80%. |
||
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx propiramu xxxxx xxxxxxxxxx 100 xx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx Xxxxxx xxxxx. |
x) |
Xxxxxxxxx methylcelulosy x xxxxxxxxx xxxx xxx xxxxxxx xxxxxx xxxx xxxxx xxx xxxxxxxxx. |
Xxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxxxx stupeň xxxxxx xx vyšší xxx X4 xxxx XX2.
Xx. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx parlamentu a Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. II xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Xx. x účinností xx 1.3.2017
Xx. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx právním xxxxxxxxx x. 30/2018 Sb. x xxxxxxxxx od 8.3.2018
Xx. XX
Xxxx nařízení xxxx oznámeno x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx služby xxxxxxxxxx xxxxxxxxxxx.
Xx. II xxxxxx právním xxxxxxxxx x. 242/2018 Xx. x účinností xx 25.10.2018
Xx. II
Technický xxxxxxx
Xxxx xxxxxxxx bylo xxxxxxxx x xxxxxxx xx xxxxxxxx Evropského xxxxxxxxxx x Rady (EU) 2015/1535 ze dne 9. xxxx 2015 x postupu xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx technických xxxxxxxx x xxxxxxxx pro xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 184/2021 Xx. s účinností xx 3.6.2021
Čl. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx právním xxxxxxxxx x. 159/2022 Xx. x účinností xx 1.7.2022
Xx. XX
Xxxxxxxxx předpis
Toto xxxxxxxx xxxx xxxxxxxx x souladu xx xxxxxxxx Evropského parlamentu x Rady (EU) 2015/1535 ze dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx informací x xxxxxxx technických předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 228/2023 Xx. x xxxxxxxxx xx 1.8.2023
Xx. II
Technický xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x souladu se xxxxxxxx Xxxxxxxxxx parlamentu x Rady (XX) 2015/1535 xx xxx 9. září 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x předpisů xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx právním xxxxxxxxx č. 52/2024 Xx. x xxxxxxxxx xx 6.3.2024
Xx. II
Technický xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 ze xxx 9. září 2015 x postupu xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX vložen právním xxxxxxxxx č. 176/2024 Xx. x xxxxxxxxx xx 1.7.2024
Xxxxxx předpis x. 463/2013 Xx. nabyl xxxxxxxxx dnem 1.1.2014.
Xx xxxxx tohoto xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx a xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Xx., kterým xx xxxx nařízení xxxxx x. 463/2013 Xx., o seznamech xxxxxxxxxx xxxxx
x xxxxxxxxx xx 1.10.2015
46/2017 Xx., xxxxxx se xxxx xxxxxxxx xxxxx č. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxx xxxxx x. 243/2015 Xx.
x účinností od 1.3.2017 s xxxxxxxx xxxxxxxxx xxxxxxxxxx, která xxxxxxxx xxxxxxxxx 1.5.2017
30/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 8.3.2018
242/2018 Sb., xxxxxx se mění xxxxxxxx vlády x. 463/2013 Xx., o xxxxxxxxx návykových látek, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 25.10.2018
184/2021 Xx., xxxxxx xx xxxx nařízení xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx předpisů
s xxxxxxxxx xx 3.6.2021
159/2022 Xx., kterým se xxxx nařízení xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxxxx předpisů
s xxxxxxxxx xx 1.7.2022
228/2023 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.8.2023
52/2024 Sb., xxxxxx xx mění nařízení xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx pozdějších xxxxxxxx
x xxxxxxxxx od 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 1.7.2024 x 1.1.2025
Znění xxxxxxxxxxxx právních xxxxx xxxxxx právních xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx předpisu.
1) Xxxxxxxx úmluva x omamných xxxxxxx, xxxxxxxxx xxx č. 47/1965 Sb., xx xxxxx Protokolu x xxxxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
Xxxxxxxx Xxxxxx v xxxxxxxxx pravomoci (XX) 2022/1326 ze xxx 18. xxxxxx 2022, xxxxxx xx mění xxxxxxx rámcového xxxxxxxxxx Xxxx 2004/757/SVV, xxxxx xxx o zahrnutí xxxxxx psychoaktivních xxxxx xx xxxxxxxx xxxxx.
2) Xxxxxx o xxxxxxxxxxxxxx látkách, xxxxxxxxx xxx č. 62/1989 Sb.
3) Xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX xx xxx 25. xxxxx 2004, kterým xx xxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxx xx xxxxx xxxxxxxxxx xxxxxxx trestných xxxx a xxxxxx x xxxxxxx nedovoleného xxxxxxx x drogami.
Směrnice Xxxxxxxxxx parlamentu x Xxxx (XX) 2017/2103 xx dne 15. xxxxxxxxx 2017, kterou xx mění xxxxxxx xxxxxxxxxx Rady 2004/757/XXX x xxxxx zahrnout xx xxxxxxxx xxxxx xxxx xxxxxxxxxxxxx xxxxx x xxxxxxx xxxxxxxxxx Xxxx 2005/387/XXX.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (XX) 2019/369 xx xxx 13. prosince 2018, xxxxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/SVV, xxxxx xxx x xxxxxxxx xxxxxx psychoaktivních xxxxx xx xxxxxxxx xxxxx.
Xxxxxxxx Xxxxxx x xxxxxxxxx xxxxxxxxx (EU) 2020/1687 xx xxx 2. xxxx 2020, xxxxxx xx xxxx xxxxxxx xxxxxxxxx rozhodnutí Xxxx 2004/757/XXX, xxxxx xxx x xxxxxxxx xxxx psychoaktivní xxxxx X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1 X-xxxxxxxxxxxx-1-xxxxxxxxx (xxxxxxxxxxxx) xx xxxxxxxx drogy.
Směrnice Xxxxxx v přenesené xxxxxxxxx (EU) 2021/802 xx xxx 12. xxxxxx 2021, xxxxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Rady 2004/757/XXX, xxxxx xxx x xxxxxxxx nových xxxxxxxxxxxxxxx xxxxx xxxxxx 3,3-xxxxxxxx-2-{[1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx} butanoát (MDMB-4en-PINACA) x xxxxxx 2-{[1-(4-fluorobutyl)-1H-indol-3-karbonyl]amino}-3,3-dimethylbutanoát (4X-XXXX-XXXX) xx xxxxxxxx xxxxx.